To restrict Cre expression to principal cells, we have used the regulatory elements of the mouse aquaporin-2 (AQP2) gene to drive Cre expression. Since AQP2 is already expressed during renal development, MR ablation took place long before the analysis performed at the adult stage. To investigate whether the early onset of MR ablation affected the adult renal sodium handling, we developed a transgene expressing the CreER T2 fusion protein under control of the regulatory elements of the AQP2 gene (AQP2CreER T2 ). Immunofluorescence revealed MR loss in the collecting duct (CD) and late connecting tubule after induction of MR ablation by tamoxifen in MR AQP2CreERT2 mice that equals the MR loss in MR AQP2Cre mice. Surprisingly, tamoxifen-independent MR loss is observed in CDs of noninduced mutants without affecting circulating aldosterone levels. Under a low-salt diet, the induced ablation of MR at the adult stage recapitulates the renal sodium wasting observed in mice with constitutive early-onset MR ablation. The AQP2CreER T2 transgene is a new tool for investigating in vivo the function of genes downstream of MR in renal ENaC-mediated sodium reabsorption by inducible somatic gene inactivation.
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T2 ; tamoxifen CONTROL OF SODIUM REABSORPTION in the kidney is essential for maintaining sodium balance and requires tight regulation of the activity of several transport proteins, which are differentially expressed in distinct functional segments of the renal tubules (1, 9) . One important regulator of sodium reabsorption is the mineralocorticoid hormone aldosterone, which activates the transcription factor mineralocorticoid receptor (MR) in its target cells (4) . Sodium reabsorption in the aldosterone-responsive distal tubular segments is mediated by the amiloridesensitive epithelial sodium channel (ENaC) present in the principal cells of the collecting duct (CD) and connecting tubule (CNT), together with the thiazide-sensitive sodiumchloride cotransporter (TSC) in the distal convoluted tubule (DCT) (8) . Germline inactivation of the MR gene in mice results in early postnatal lethality due to massive loss of sodium and water. These MR knockout mice show strongly impaired ENaC activity in the kidney and colon (2) . To overcome postnatal lethality and to address the role of MR in renal ENaC-mediated sodium reabsorption, we have previously generated mice lacking MR in renal principal cells using the Cre-loxP recombination system that allows somatic cellspecific gene inactivation (10) . To drive the expression of the Cre recombinase, we have used the regulatory elements of the mouse aquaporin-2 (AQP2) gene. AQP2 is an apical water channel, which is coexpressed with ENaC in principal cells of the CD and CNT (8) and is already expressed during renal development (7, 12) . AQP2Cre transgenic mice were bred with mice carrying a conditional MR allele (3) to generate mutant mice (MR AQP2Cre ). Under a standard diet, MR AQP2Cre mice showed unaltered renal sodium excretion but strongly increased plasma aldosterone levels. Once challenged with a low-sodium diet, MR AQP2Cre mice showed increased renal sodium and water excretion associated with a continuous loss of body weight. These data demonstrated that targeted inactivation of MR in CD and late CNT causes renal sodium and water loss, which can be compensated by increased aldosterone levels acting on upstream renal tubular segments under a standard diet, but no longer when sodium supply is limited.
Since AQP2 is already strongly expressed during renal (preand postnatal) development, the ablation of MR in MR AQP2Cre mice took place long before the analysis of their renal sodium handling at the adult stage. To investigate whether the early onset of MR ablation (with constitutively elevated plasma aldosterone levels) led to developmental adaptations that affected adult sodium homeostasis, we developed a transgene that allows induction of MR ablation in AQP2-expressing cells at the adult stage. To be able to regulate Cre-mediated recombination, we made use of the CreER T2 protein, a fusion of Cre recombinase and the mutated ligand-binding domain of the human estrogen receptor (LBD). The LBD contains a nuclear localization signal that is unmasked upon ligand binding. Two point mutations in the LBD allow binding of the synthetic ligand tamoxifen and prevent activation of the CreER T2 by endogenous estradiol. Therefore, the unliganded form of the CreER T2 fusion protein resides in the cytoplasm and translocates to the nucleus only upon tamoxifen binding, thus mediating site-specific recombination that results in tamoxifendependent gene inactivation with low leakiness and highly efficient induction (5, 6) .
Using a conditional (flox) MR allele (3), we could show that after tamoxifen treatment MR loss is observed in CNT and CD that results in sodium wasting under a low-sodium diet. Tamoxifen-independent recombination was found in the CD, however, without affecting the circulating plasma aldosterone levels. The AQP2CreER T2 transgene is a new and valuable tool for investigating in vivo the role of MR target genes in aldosterone-driven ENaC-mediated renal sodium reabsorption by induced gene inactivation at the adult stage.
METHODS
Generation of transgenic mice. Transgenic mice expressing the CreER T2 fusion protein under the control of the AQP2 gene (AQP2CreER T2 mice) were generated as described for the constitutive AQP2Cre mice (10) . Briefly, the PAC used for the generation of the constitutive AQP2Cre transgene, which was isolated from a mouse PAC library and contains a 156-kb genomic DNA fragment, was modified by homologous recombination in bacteria to introduce the CreER T2 fusion protein coding sequence at the ATG of the AQP2 locus (Fig. 1A) . The modified genomic fragment containing the CreER T2 fusion protein knock-in was microinjected into the pronucleus of FVB/N mouse oocytes (11 (3). The genetic background of the mice used in this study was a mixture of FVB/N and C57Bl/6. All experimental procedures were approved by German animal welfare authorities and carried out in accordance with the local animal welfare act and the European Community Council Directive (86/609/EEC).
Animal treatment. Tamoxifen (Sigma) was dissolved in a sunflower seed oil/ethanol (10:1) mixture at a final concentration of 10 mg/ml. Two-month-old mice were injected intraperitoneally with either 1 mg of tamoxifen or 100 l of the sunflower seed oil/ethanol mixture (vehicle) once a day for 5 consecutive days. Experimental animals for metabolic balance studies and immunohistochemistry were put on either a standard or a low-sodium diet 1 day after the last injection and euthanized 10 days later.
Immunohistochemistry and immunofluorescence. Kidneys were processed, and paraffin or cryosections were incubated with the different antibodies as previously described (10) . Cell nuclei were stained with the DNA dye 4,6-diamidino-2-phenylindole dihydrochloride (DAPI; Boehringer Mannheim).
Morphometry. Cryosections costained with DAPI and antibodies against AQP2 and MR were analyzed with a Leica microscope using the ϫ40 objective. AQP2-positive cells in CNT, initial portions of cortical collecting ducts (iCCD), and end portions of cortical collecting ducts (eCCD) were identified based on their typical localization around radial vessels in the cortical labyrinth (CNTs), in medullary rays close to the renal capsule (iCCD), or close to the border from the renal cortex to the outer medulla (eCCD). For each of these tubule segments, the percentage of MR-positive cell nuclei in AQP2-positive cells was determined. At least 200 cell nuclei/ mouse and tubule segment were analyzed.
Metabolic balance studies. Two-month-old mice were fed a standard diet (0.18% sodium; ssniff) or a low-sodium diet (sodium content in mineral mix Ͻ0.01%, global sodium content in the diet: 0.02%; ssniff) for 10 days. Mice were placed in mouse metabolic cages for 24 h to determine water and food consumption and to collect urine.
Urine and plasma analysis. Urinary sodium was measured using EML100 System 625 (Radiometer) and aldosterone by radioimmunoassay (Coat-a-Count, Diagnostics Products).
Statistics. All measurements are presented as means Ϯ SE. The data were analyzed using an unpaired two-tailed Student's t-test.
RESULTS
To drive renal expression of the CreER T2 fusion protein to allow induced gene inactivation, we used the same 156-kb genomic fragment containing the regulatory elements of the mouse AQP2 gene that we have been using for the constitutive AQP2Cre transgene (10) . The genomic fragment was modified by homologous recombination in bacteria to introduce the CreER T2 coding sequence at the ATG of the AQP2 locus (Fig.  1A) . After removal of the ampicillin resistance cassette, the modified fragment (AQP2CreER T2 transgene) was purified and microinjected into oocytes. Transgenic founder animals were identified by PCR and dot blot analysis of tail DNA. The F1 progeny was used to determine the copy number of the transgene by Southern blotting. Three transgenic lines with different copy numbers of the transgene (1, 4, and 9 copies) were established and analyzed for Cre expression by immunohistochemistry on kidney paraffin sections. Transgenic animals were intraperitoneally injected with 1 mg tamoxifen or vehicle 12 h before dispatch to visualize Cre expression. The expression of the AQP2CreER T2 transgene resembles that of the endogenous AQP2 gene and of the constitutive AQP2Cre transgene (10) . In the different transgenic lines, the expression of the CreER T2 protein shows copy number-dependent quantitative differences but an identical expression pattern (data not shown). As expected, translocation of CreER T2 was induced by tamoxifen treatment (Fig. 1, B and C) . The four-copy line was chosen for further analysis. To achieve inducible renal principal cell MR ablation, we crossed mice harboring a conditional MR allele (MR flox ) (3) with transgenic AQP2CreER T2 mice to obtain MR flox/flox /AQP2CreER T2 (MR AQP2CreERT2 ) mice. Eight-week-old MR AQP2CreERT2 mice were treated once a day with 1 mg tamoxifen or vehicle for 5 consecutive days. Thereafter, they were put on a low-sodium diet or left on a standard diet and were euthanized 10 days later. Vehicle-treated MR AQP2CreERT2 mice as well as vehicle-or tamoxifen-treated controls on either a standard or low-sodium diet were used for comparison.
To determine Cre-mediated ablation of MR expression, double immunofluorescence for AQP2 and MR was performed on kidney cryosections. In control mice, MR was well detectable in DCT, CNT, and CCD. In vehicle-injected MR AQP2CreERT2 mice, MR expression was preserved in DCT and CNT. However, tamoxifen-independent MR loss was observed in most of the AQP2-positive cells of the CCD. This tamoxifen-independent MR deletion increased along the axis of the CCD in parallel to the increasing AQP2 abundance. In tamoxifen-injected MR AQP2CreERT2 mice, MR was absent in AQP2-positive cells of the CCD and CNT, but remained in AQP2-negative cells of the DCT (Fig. 2) . To further substantiate these qualitative observations, the percentage of MRpositive cell nuclei in AQP2-positive, segment-specific cells was determined for the CNT as well as the initial and end portion of the CCD (iCCD and eCCD, respectively) in control as well as vehicle-and tamoxifen-injected MR Under a standard diet, tamoxifen-induced MR AQP2CreERT2 mice displayed elevated plasma aldosterone levels, whereas noninduced MR AQP2CreERT2 mice or tamoxifen-induced control mice showed normal levels (control-tamoxifen: 671 Ϯ 46 pg/ml, n ϭ 2; MR AQP2CreERT2 -vehicle: 718 Ϯ 298 pg/ml, n ϭ 5, P ϭ 0.89 vs. control-tamoxifen; MR AQP2CreERT2 -tamoxifen: 4,870 Ϯ 881 pg/ml, n ϭ 5, P ϭ 0.007 vs. MR AQP2CreERT2 -vehicle). The plasma aldosterone levels measured in control mice did not differ from the values determined in control animals within a similar genetic background (P Ͼ 0.1) (10) . Similarly, the plasma aldosterone levels measured in the tamoxifen-induced MR AQP2CreERT2 mutants did not differ from the levels in early-onset MR AQP2Cre mutants (P Ͼ 0.5) (10). Since the plasma aldosterone levels did not indicate renal sodium wasting under a standard diet, 2-mo-old MR AQP2CreERT2 mice were challenged with a low-sodium diet for 10 days. Tamoxifen-induced and -noninduced MR AQP2CreERT2 mice as well as well as vehicle-and tamoxifen-treated control mice all showed similar sodium intake, since no significant difference in food consumption was measured (Table 1) . Vehicle-and tamoxifen-treated control mice as well as vehicle-treated
MR
AQP2CreERT2 mice all showed similar 24-h urinary volume and 24-h urinary sodium excretion. In contrast, tamoxifentreatment of MR AQP2CreERT2 mice induced a strong increase in 24-h urine volume and sodium excretion (Fig. 3) . Comparison of the 24-h urinary sodium excretion values to the ones determined for MR AQP2Cre mice and their control littermates that were bred in a similar genetic background (10) did not reveal significant changes, neither for controls nor for mutants (P Ͼ 0.1). Comparison of the 24-h urinary volume revealed no difference in controls. However, induced mutants showed a stronger increase than early-onset constitutive mutants com- pared with the respective littermate controls. The induced mutants showed increased water intake compared with controls or noninduced MR AQP2CreERT2 mice. However, the difference did not reach statistical significance (Table 1) .
DISCUSSION
Germline inactivation of the MR gene in mice results in early postnatal lethality due to massive loss of sodium and water (2) . To address the role of MR in renal ENaC-mediated sodium reabsorption, we have previously generated mice lacking MR in renal principal-cells (MR AQP2Cre mice). In contrast to MR inactivation in the germline (2), early-onset inactivation of the MR gene in renal principal-cells did not impair survival. However, besides normal growth and unaltered sodium balance, if fed with a standard diet, MR AQP2Cre mice showed strongly increased plasma aldosterone levels (10) . To investigate whether the early loss of MR and the permanently elevated aldosterone levels have led to developmental adaptations that affected the renal sodium handling in adult MR AQP2Cre mice, we generated mice with renal MR ablation induced at the adult stage (MR AQP2CreERT2 mice). The transgene expressing CreER T2 (AQP2CreER T2 ) contains the same regulatory elements of the AQP2 gene as the AQP2Cre transgene. Surprisingly, the noninduced MR AQP2CreERT2 mice already showed MR loss in AQP2-positive cells of the CCD (ϳ68% in eCCD and 97% in iCCD), indicating that the control of Cre activity exerted by the ER T2 domain is not tight. We observed a gradual increase in tamoxifen-independent recombination from CNT via iCCD to eCCD resembling the reported AQP2 expression pattern with increasing abundance along these tubular segments (8) . Therefore, we conclude that the strength of CreER T2 expression is responsible for ligand-independent recombination. Using a transgene driving CreER T2 in neurons of the forebrain, we also observed higher tamoxifen-independent recombination in cells with higher CreER T2 expression (5) . Since the AQP2 promoter gives very strong expression already prenatally (7, 12) , the use of other regulatory elements driving lower expression and a later onset should lead to lower ligandindependent recombination. Interestingly, the tamoxifen-independent MR loss in the CCD did not lead to an increase in plasma aldosterone, indicating that no deficiency in renal aldosterone signaling is perceived. Tamoxifen treatment resulted in strong MR loss in the CNT and almost complete MR loss in iCCD and eCCD, leading to elevated plasma aldosterone and increased urinary sodium excretion under sodium restriction similar to that observed in the MR AQP2Cre mice. Induced MR AQP2CreERT2 showed a stronger increase in 24-h urinary volume than MR AQP2Cre mice compared with the respective littermate controls. However, induced MR AQP2CreERT2 mice also showed increased water consumption that was not observed in MR AQP2Cre mice. Taken together, our data show that the important site of aldosterone-driven, renal principal cell-mediated sodium reabsorption is the CNT and the iCCD, since constitutive ablation of MR in eCCD and most of iCCD principal cells did not increase plasma aldosterone levels. The early onset and the induced ablation of MR in AQP2-expressing cells cause similar renal sodium wasting. Therefore, we conclude that changes in renal sodium handling in adult animals due to MR deficiency in principal cells are not affected by an early onset of the mutation. Furthermore, the MR AQP2CreERT2 mice represent a rapid "turn-on" system for an acute strong plasma aldosterone increase, allowing the study of acute effects of hyperaldosteronism in kidney and other aldosterone target tissues, like the cardiovascular system. Moreover, the AQP2CreER T2 transgene is a new tool for investigating in vivo the function of genes downstream of MR in renal ENaC-mediated sodium reabsorption by inducible somatic gene inactivation.
